Research and Markets: In-Vitro Diagnostic (IVD) Market (Applications, End-Users & Types) - Trends & Global Forecasts (Major & Emerging Markets - G7, Japan & Bric) (2011 - 2016)

DUBLIN--(BUSINESS WIRE)--Research and Markets(http://www.researchandmarkets.com/research/3d1c5b/invitro_diagnosti) has announced the addition of the "In-Vitro Diagnostic (Ivd) Market (Applications, End-Users & Types) - Trends & Global Forecasts (Major & Emerging Markets - G7, Japan & Bric) (2011 - 2016)" report to their offering.

“In-Vitro Diagnostic (Ivd) Market (Applications, End-Users & Types) - Trends & Global Forecasts (Major & Emerging Markets - G7, Japan & Bric) (2011 - 2016)”

The global IVD market was valued at $44 billion in the year 2011, growing at a CAGR of 7.8% from 2011 to 2016. The U.S. represented the biggest market for the IVD equipments accounting for a share of 47% of the total IVD market in the year 2011.

The European region accounted for 31% of the global IVD market with Germany accounting for the largest share of 23.24% followed France (16.89%) and Italy (16.41%) of the total IVD market.

The Asian region is expected to be ruled by the emerging economies such as China and India, show the highest CAGR by the year 2016. The Chinese IVD market is taking frog leap amongst the emerging nations, followed by India, Russia, and Brazil. The major driving factor for the IVD industry to boom in the emerging countries is the government funding and improved healthcare facilities.

However, the condition is completely reverse in the developed countries such as North America and Eu-5 as these countries are facing major financial crisis and thus having deep cuts on the healthcare budgets with limited reimbursements provided on the clinical testing and the newly introduced tests in the market thus hampering the growth of IVD industry.

The major factors driving the growth of the IVD market is increased patient awareness, patient self testing, and increasing baby booming population across the globe. Advancement in the technology bringing more of automated tests is also one of the major drivers for the growth of IVD market.

Other major drivers for the growth of the IVD industry is rise in the number of diseases like respiratory infections, hospital acquired infections, and sexually transmitted diseases. Similarly rise in the chronic diseases such as diabetes, hypertension, cardiovascular diseases, and cancer are driving the overall IVD market.

Key Topics Covered:

1 Introduction

2 Executive Summary

3 Market Overview

4 Clinical Chemistry

5 Immunoassays

6 Molecular Diagnostics 7 Hematology

8 Microbiology

9 Others

10 Geographical Analysis

11 Competitive Landscape

12 Company Profiles

Companies Mentioned:

• Abbott Diagnostics Inc
• Alere Inc
• Arkray Inc
• Beckman Coulter Inc
• Becton, Dickinson And Company
• Biomerieux
• Bio-Rad Laboratories Inc
• Diasorin Diagnostic S.P.A
• Diagnostica Stago Sas
• Gen-Probe Incorporated
• Hologic Inc
• Horiba Ltd
• Luminex Corporation
• Mindray Medical International Limited
• Novartis International Ag
• Ortho Clinical Diagnostics (Jnj Company)
• Qiagen N.V.
• Roche Diagnostics Limited
• Siemens Healthcare
• Sysmex Corporation
• Thermo Fisher Scientific Inc

For more information visit http://www.researchandmarkets.com/research/3d1c5b/invitro_diagnosti